as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹5,536.5
Change
+31.5 (0.57%)
Open
₹5,505.0
Prev. Close
₹5,505.0
Day High
₹5,659.5
Day Low
₹5,461.5
Volume Analysis
Traded
7,906
Delivered
2,942
Delivery %
37.21%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (33.0%)
Weaknesses (0)
No signal for this stock
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹5,841.5 | ₹5,750.5 | ₹5,643.5 | ₹5,552.5 | ₹5,445.5 | ₹5,354.5 | ₹5,247.5 |
| Fibonacci | ₹5,750.5 | ₹5,674.86 | ₹5,628.14 | ₹5,552.5 | ₹5,476.86 | ₹5,430.14 | ₹5,354.5 |
| Camarilla | ₹5,590.95 | ₹5,572.8 | ₹5,554.65 | ₹5,552.5 | ₹5,518.35 | ₹5,500.2 | ₹5,482.05 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-3.25%
1 Week
-4.69%
1 Month
+9.68%
3 Months
-5.01%
6 Months
-0.3%
1 Year
-6.26%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
DuPont ROE Breakdown
47.92%
Net margin 23.22% × asset turnover 1.34x × equity multiplier 1.54x
Company Overview
Sector
Healthcare
Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.
TopFund Analysis
Procter & Gamble Health L holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 73/100. The strongest factor is Financial Strength (100/100), while Institutional Ownership (34/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (33.0%). FII holding has been falling.
TopFund Score — Fundamentals Quality
73/100 — GoodData confidence: 74/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Growth
Cash Flow
Corporate Governance
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
SEBI special window for physical share transfer relodgement extended to February 4, 2027; RTA office moves December 1, 2026.
KFin Technologies shifts corporate office from 1 December 2026; company's registered office unchanged.
Q2 FY26 sales rose 18% to ₹376 crore; PAT increased 26% to ₹112 crore.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Sep 2023 (S) | Dec 2023 (S) | Mar 2024 (S) | Jun 2024 (S) | Sep 2024 (S) | Dec 2024 (S) | Mar 2025 (S) | Jun 2025 (S) | Sep 2025 (S) | Dec 2025 (S) | Mar 2026 (S) | Jun 2026 (S) | Sep 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 305 | 310 | 252 | 284 | 313 | 310 | 311 | 339 | 325 | 374 | 370 | 364 | 382 |
| Expenses + | 216 | 208 | 185 | 236 | 199 | 186 | 230 | 248 | 205 | 263 | 235 | 264 | 230 |
| Operating Profit | 89 | 102 | 67 | 48 | 114 | 123 | 81 | 90 | 120 | 110 | 136 | 100 | 152 |
| OPM % | 29.0% | 33.0% | 27.0% | 17.0% | 36.0% | 40.0% | 26.0% | 27.0% | 37.0% | 30.0% | 37.0% | 27.0% | 40.0% |
| Other Income + | 6 | 5 | 2 | -18 | 3 | 4 | 3 | 4 | 5 | 4 | 4 | 36 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 6 | 7 | 7 | 7 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 6 | 6 |
| Profit before tax | 88 | 100 | 63 | 23 | 111 | 122 | 79 | 89 | 119 | 109 | 133 | 129 | 150 |
| Tax % | 26.0% | 28.0% | 26.0% | 26.0% | 26.0% | 25.0% | 22.0% | 25.0% | 26.0% | 29.0% | 29.0% | 26.0% | 26.0% |
| Net Profit + | 66 | 72 | 47 | 17 | 82 | 91 | 61 | 66 | 89 | 78 | 95 | 96 | 112 |
| EPS in Rs | 40 | 43 | 28 | 10 | 50 | 55 | 37 | 40 | 53 | 47 | 57 | 58 | 67 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| YoY Sales growth | 2 | 0 | -21 | -6 | 3 | 0 | 23 | 19 | 4 | 21 | 19 | 7 | 18 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Dec 2015 (S) | Dec 2016 (S) | Dec 2017 (S) | Dec 2018 (S) | Dec 2019 (S) | Jun 2020 (S) 18m | Jun 2021 (S) | Jun 2022 (S) | Jun 2023 (S) | Jun 2024 (S) | Mar 2025 (S) 9m | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 940 | 993 | 698 | 849 | 927 | 1,356 | 1,009 | 1,114 | 1,230 | 1,151 | 934 | 1,408 |
| Expenses + | 855 | 877 | 621 | 701 | 723 | 1,037 | 762 | 846 | 905 | 845 | 616 | 949 |
| Operating Profit | 85 | 116 | 77 | 148 | 204 | 319 | 246 | 268 | 325 | 307 | 319 | 459 |
| OPM % | 9.0% | 12.0% | 11.0% | 17.0% | 22.0% | 24.0% | 24.0% | 24.0% | 26.0% | 27.0% | 34.0% | 33.0% |
| Other Income + | 22 | 24 | 74 | 768 | 48 | 66 | 18 | 13 | 18 | -5 | 10 | 15 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 1 |
| Depreciation | 23 | 25 | 19 | 21 | 17 | 29 | 30 | 27 | 28 | 27 | 17 | 24 |
| Profit before tax | 83 | 115 | 132 | 895 | 234 | 355 | 233 | 253 | 314 | 273 | 312 | 450 |
| Tax % | 36.0% | 31.0% | 29.0% | 6.0% | 32.0% | 28.0% | 24.0% | 24.0% | 27.0% | 26.0% | 25.0% | 27.0% |
| Net Profit + | 54 | 79 | 94 | 839 | 159 | 254 | 177 | 193 | 229 | 201 | 234 | 327 |
| EPS in Rs | 32 | 48 | 57 | 505 | 96 | 153 | 107 | 116 | 138 | 121 | 141 | 197 |
| Dividend Payout % | 23.0% | 23.0% | 27.0% | 87.0% | 0.0% | 150.0% | 122.0% | 45.0% | 69.0% | 215.0% | 89.0% | 104.0% |
| Sales growth | 8 | 6 | -30 | 22 | 9 | 60 | -26 | 10 | 10 | -6 | -24 | 51 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Dec 2015 (S) | Dec 2016 (S) | Dec 2017 (S) | Dec 2018 (S) | Dec 2019 (S) | Jun 2020 (S) | Jun 2021 (S) | Jun 2022 (S) | Jun 2023 (S) | Jun 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | Sep 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 575 | 647 | 717 | 1,524 | 800 | 890 | 687 | 600 | 734 | 522 | 520 | 508 | 641 |
| Borrowings + | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 3 | 12 | 10 | 8 | 9 | 7 |
| Other Liabilities + | 192 | 215 | 258 | 219 | 250 | 269 | 275 | 269 | 338 | 247 | 250 | 308 | 349 |
| Total Liabilities | 784 | 879 | 991 | 1,759 | 1,067 | 1,176 | 986 | 888 | 1,101 | 794 | 794 | 841 | 1,015 |
| Fixed Assets + | 132 | 111 | 115 | 104 | 101 | 101 | 104 | 112 | 144 | 128 | 116 | 102 | 102 |
| CWIP | 7 | 30 | 9 | 17 | 11 | 21 | 39 | 41 | 32 | 6 | 11 | 14 | 10 |
| Investments | 42 | 28 | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 603 | 711 | 797 | 1,639 | 954 | 1,053 | 843 | 736 | 925 | 660 | 667 | 726 | 902 |
| Total Assets | 784 | 879 | 991 | 1,759 | 1,067 | 1,176 | 986 | 888 | 1,101 | 794 | 794 | 841 | 1,015 |
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Dec 2015 (S) | Dec 2016 (S) | Dec 2017 (S) | Dec 2018 (S) | Dec 2019 (S) | Jun 2020 (S) | Jun 2021 (S) | Jun 2022 (S) | Jun 2023 (S) | Jun 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 83 | 107 | 54 | -130 | — | 235 | 247 | 170 | 236 | 228 | 169 | 338 |
| Cash from Investing Activity + | -68 | -75 | -48 | 1,270 | — | 165 | -32 | -26 | -22 | -7 | 10 | 1 |
| Cash from Financing Activity + | -12 | -15 | -22 | -30 | — | -883 | -387 | -289 | -98 | -418 | -235 | -344 |
| Net Cash Flow | 4 | 17 | -16 | 1,109 | — | -483 | -172 | -145 | 116 | -197 | -56 | -5 |
| Free Cash Flow | 38 | 75 | 24 | -157 | — | 212 | 196 | 132 | 198 | 207 | 168 | 323 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 136 | 138 | 147 | 117 | — | 106 | 128 | 87 | 100 | 102 | 78 | 96 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 27.92% | 28.22% | 27.24% | 26.74% | 26.47% | 27.11% | 27.03% | 27.05% | 27.37% | 28.3% | 29.41% | 29.13% |
| Promoters | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| FII | 7.6% | 6.24% | 6.39% | 6.61% | 7.01% | 6.86% | 6.99% | 7.24% | 6.97% | 6.2% | 6.33% | 6.43% |
| DII | 12.66% | 13.72% | 14.56% | 14.84% | 14.71% | 14.21% | 14.15% | 13.9% | 13.84% | 13.67% | 12.44% | 12.63% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Procter & Gamble Health L (this stock) | — | — | — | — |
| Sun Pharmaceutical Ind L | 451,075 | 36.7 | 5.05 | 16.0% |
| Divi S Laboratories Ltd | 294,139 | 86.1 | 16.34 | 16.5% |
| Torrent Pharmaceuticals L | 177,632 | 81.8 | 9.67 | 27.4% |
| Apollo Hospitals Enter. L | 125,893 | 55.6 | 11.86 | 21.5% |
| Laurus Labs Limited | 125,380 | 93.6 | 20.73 | 18.3% |
| Zydus Lifesciences Ltd | 118,693 | 26.2 | 4.27 | 21.2% |
Which Mutual Funds Hold Procter & Gamble Health L?
Frequently Asked Questions about Procter & Gamble Health L
Procter & Gamble Health L (PGHL) closed at ₹5,536.5 on NSE on 19 November 2026, up 31.5 (0.57%) from the previous close.
Procter & Gamble Health L trades on the NSE (National Stock Exchange of India) under the symbol PGHL.
Procter & Gamble Health L has a TopFund Quality Score of 73/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Procter & Gamble Health L?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.